Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine

被引:3
|
作者
Parajuli, Niraj [1 ]
Adhikary, Sabeena [1 ]
Karki, Anupama [1 ]
Tiwari, Sumida [2 ]
机构
[1] Bir Hosp, Natl Acad Med Sci, Dept Dermatol & Venereol, Kathmandu 44600, Nepal
[2] Bir Hosp, Natl Acad Med Sci, Dept Pathol, Kathmandu, Nepal
来源
关键词
DIAGNOSIS;
D O I
10.4269/ajtmh.20-0918
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cutaneous leishmaniasis (CL) can present with various skin lesions ranging from a single ulcer to diffuse multiple nodules. Here, we present a case of a 67-year-old man with a large erythematous well-defined indurated plaque over the left face for a duration of 4 months. A slit skin smear was performed, and it was stained with Giemsa stain which showed multiple amastigotes confirming the diagnosis of CL. Oral miltefosine was started at a dose of 150 mg/day but had to be stopped after 20 days as the patient developed diarrhea, bipedal edema, and renal impairment. This case emphasizes an uncommon variant of CL and the role of systemic treatment with oral miltefosine and its associated adverse effects.
引用
收藏
页码:643 / 645
页数:3
相关论文
共 50 条
  • [41] Development of miltefosine as an oral treatment for leishmaniasis
    Sindermann, H.
    Engel, J.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2006, 100 : S17 - S20
  • [42] Trial of oral miltefosine for visceral leishmaniasis
    Sundar, S
    Rosenkaimer, F
    Makharia, MK
    Goyal, AK
    Mandal, AK
    Voss, A
    Hilgard, P
    Murray, HW
    LANCET, 1998, 352 (9143): : 1821 - 1823
  • [43] Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis
    Ware, JeanAnne M.
    O'Connell, Elise M.
    Brown, Thomas
    Wetzler, Lauren
    Talaat, Kawsar R.
    Nutman, Thomas B.
    Nash, Theodore E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2457 - E2462
  • [45] Treatment of New World cutaneous leishmaniasis with miltefosine
    Soto, J.
    Berman, J.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2006, 100 : S34 - S40
  • [46] Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses
    Zerpa, O.
    Ulrich, M.
    Blanco, B.
    Polegre, M.
    Avila, A.
    Matos, N.
    Mendoza, I.
    Pratlong, F.
    Ravel, C.
    Convit, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (06) : 1328 - 1335
  • [47] Efficacy of Miltefosine for the Treatment of American Cutaneous Leishmaniasis
    Velez, Ivan
    Lopez, Liliana
    Sanchez, Ximena
    Mestra, Laureano
    Rojas, Carlos
    Rodriguez, Elwin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (02): : 351 - 356
  • [48] Miltefosine: An Oral Drug for Visceral Leishmaniasis
    Prasad R.
    Kumar R.
    Jaiswal B.P.
    Singh U.K.
    The Indian Journal of Pediatrics, 2004, 71 (2) : 143 - 144
  • [49] Oral miltefosine for Indian visceral leishmaniasis
    Sundar, S
    Jha, TK
    Thakur, CP
    Engel, J
    Sindermann, H
    Fischer, C
    Junge, K
    Bryceson, A
    Berman, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (22): : 1739 - 1746
  • [50] Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis
    del Mar Castro, Maria
    Adelaida Gomez, Maria
    Kip, Anke E.
    Cossio, Alexandra
    Ortiz, Eduardo
    Navas, Adriana
    Dorlo, Thomas P. C.
    Gore Saravia, Nancy
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)